Rowlandmiller & PARTNERS.ADV Sells 1,284 Shares of Maximus, Inc. (NYSE:MMS)

Rowlandmiller & PARTNERS.ADV reduced its stake in Maximus, Inc. (NYSE:MMS) by 4.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,359 shares of the health services provider’s stock after selling 1,284 shares during the period. Rowlandmiller & PARTNERS.ADV’s holdings in Maximus were worth $2,549,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. V Square Quantitative Management LLC bought a new position in Maximus in the third quarter worth about $25,000. GAMMA Investing LLC grew its holdings in shares of Maximus by 224.5% during the second quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock valued at $29,000 after buying an additional 238 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Maximus by 201.5% during the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after buying an additional 262 shares during the last quarter. Archer Investment Corp grew its holdings in shares of Maximus by 8,788.9% during the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock valued at $69,000 after buying an additional 791 shares during the last quarter. Finally, Ariadne Wealth Management LP purchased a new stake in shares of Maximus during the second quarter valued at approximately $90,000. 97.21% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, insider Michelle F. Link sold 1,363 shares of Maximus stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the sale, the insider now owns 6,567 shares in the company, valued at $607,841.52. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.40% of the stock is owned by corporate insiders.

Maximus Trading Up 0.6 %

NYSE:MMS opened at $87.48 on Friday. The company’s 50 day moving average price is $90.03 and its 200-day moving average price is $87.35. Maximus, Inc. has a 52 week low of $72.81 and a 52 week high of $93.97. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.61. The stock has a market cap of $5.32 billion, a price-to-earnings ratio of 22.96 and a beta of 0.76.

Maximus (NYSE:MMS) last released its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share for the quarter, topping the consensus estimate of $1.47 by $0.27. Maximus had a net margin of 5.59% and a return on equity of 20.91%. The business had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same period last year, the firm earned $0.78 earnings per share. The company’s quarterly revenue was up 10.6% on a year-over-year basis. On average, equities research analysts forecast that Maximus, Inc. will post 6.12 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, November 30th. Shareholders of record on Friday, November 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.37%. Maximus’s payout ratio is currently 31.50%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.